International Clinical Trial: Characteristics of changes in intestinal flora after therapy of liraglutide alone or combined with probiotics in T2DM patients

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118507) titled 'Characteristics of changes in intestinal flora after therapy of liraglutide alone or combined with probiotics in T2DM patients' on Feb. 6.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Yunnan First People's Hospital

Condition: T2DM

Intervention: Conventional comprehensive treatment group:None Liraglutide treatment group:None

Recruitment Status: Not Recruiting

Phase: Retrospective study

Date of First Enrollment: 2026-03-01

Target Sample Size: Conventional comprehensive treatment group:45;Liraglutide treatment group:15;combined probiotics treatment group:15;

Countries o...